Paclitaxel has been shown to activate IL-8 transcriptionally in ovarian carcinoma cells [47] and increases IL-8 synthesis in a subset of human lung carcinoma cell lines through an NF-κB-dependent mechanism [36]. This evidence concerns the gene NFKB1 and lung carcinoma.